Search Results
-
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
-
‘Military police’ cells stem autoimmunity
A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.
-
Common genetic profile linked to drug reaction
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.
-
When can you vaccinate your kids?
Stanford pediatricians helped conduct clinical trials of COVID-19 vaccines for children. Data from the study will be submitted to the Food and Drug Administration for consideration.
-
Allergies to COVID-19 vaccines mostly mild
In a study of mRNA-based COVID-19 vaccine doses given at Stanford Medicine, vaccine allergies were rare, mild and mostly triggered by a vaccine additive, not the mRNA.
-
Endocannabinoids and epilepsy
Release of the brain’s equivalent of THC, marijuana’s active component, reduces seizure activity but leads to post-seizure oxygen deprivation in the brain, Stanford scientists and their collaborators have shown.
-
Purifying antibiotic could reduce its risk to hearing
Scientists have discovered a simple method of reformulating gentamicin, a commonly used and highly effective antibiotic, that could reduce the risk it poses of causing deafness.
-
$14.3 million to develop broad-spectrum drugs
The Stanford researcher is pursuing antiviral drugs with broad efficacy against enteroviruses, which cause common colds and polio, and coronaviruses including the one that causes COVID-19.